XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   177,000,963      
Beginning balance at Dec. 31, 2021 $ 74,008 $ 1 $ 1,536,800 $ 6 $ (1,462,799)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of issuance costs (in shares)   4,404,600      
Issuance of common stock, net of    issuance costs 7,178 $ 1 7,177    
Proceeds from sale of stock under employee stock purchase plan (in shares)   191,146      
Proceeds from sale of stock under    employee stock purchase plan 367   367    
Stock-based compensation expense 4,536   4,536    
Restricted stock unit vesting (in shares)   1,789,326      
Net income (loss) (63,509)       (63,509)
Ending balance (in shares) at Mar. 31, 2022   183,386,035      
Ending balance at Mar. 31, 2022 22,580 $ 2 1,548,880 6 (1,526,308)
Beginning balance (in shares) at Dec. 31, 2021   177,000,963      
Beginning balance at Dec. 31, 2021 74,008 $ 1 1,536,800 6 (1,462,799)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (88,155)        
Ending balance (in shares) at Sep. 30, 2022   183,951,583      
Ending balance at Sep. 30, 2022 8,259 $ 2 1,559,206 6 (1,550,955)
Beginning balance (in shares) at Mar. 31, 2022   183,386,035      
Beginning balance at Mar. 31, 2022 22,580 $ 2 1,548,880 6 (1,526,308)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 6,841   6,841    
Exercise of options (in shares)   142,440      
Exercise of options 67   67    
Restricted stock unit vesting (in shares)   176,179      
Net income (loss) 29,449       29,449
Ending balance (in shares) at Jun. 30, 2022   183,704,654      
Ending balance at Jun. 30, 2022 58,937 $ 2 1,555,788 6 (1,496,859)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Proceeds from sale of stock under employee stock purchase plan (in shares)   144,000      
Proceeds from sale of stock under    employee stock purchase plan 43   43    
Stock-based compensation expense 3,375   3,375    
Restricted stock unit vesting (in shares)   102,929      
Net income (loss) (54,096)       (54,096)
Ending balance (in shares) at Sep. 30, 2022   183,951,583      
Ending balance at Sep. 30, 2022 $ 8,259 $ 2 1,559,206 6 (1,550,955)
Beginning balance (in shares) at Dec. 31, 2022 184,135,714 184,135,714      
Beginning balance at Dec. 31, 2022 $ 5,230 $ 2 1,562,247 6 (1,557,025)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Proceeds from sale of stock under employee stock purchase plan (in shares)   103,500      
Proceeds from sale of stock under    employee stock purchase plan 34   34    
Stock-based compensation expense 2,489   2,489    
Restricted stock unit vesting (in shares)   1,596,732      
Net income (loss) (26,878)       (26,878)
Ending balance (in shares) at Mar. 31, 2023   185,835,946      
Ending balance at Mar. 31, 2023 $ (19,125) $ 2 1,564,770 6 (1,583,903)
Beginning balance (in shares) at Dec. 31, 2022 184,135,714 184,135,714      
Beginning balance at Dec. 31, 2022 $ 5,230 $ 2 1,562,247 6 (1,557,025)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ (52,539)        
Ending balance (in shares) at Sep. 30, 2023 188,313,807 188,313,807      
Ending balance at Sep. 30, 2023 $ (39,422) $ 2 1,570,134 6 (1,609,564)
Beginning balance (in shares) at Mar. 31, 2023   185,835,946      
Beginning balance at Mar. 31, 2023 (19,125) $ 2 1,564,770 6 (1,583,903)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 3,490   3,490    
Restricted stock unit vesting (in shares)   2,292,923      
Net income (loss) (11,172)       (11,172)
Ending balance (in shares) at Jun. 30, 2023   188,128,869      
Ending balance at Jun. 30, 2023 (26,807) $ 2 1,568,260 6 (1,595,075)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Proceeds from sale of stock under employee stock purchase plan (in shares)   96,694      
Proceeds from sale of stock under    employee stock purchase plan 50   50    
Stock-based compensation expense 1,824   1,824    
Restricted stock unit vesting (in shares)   88,244      
Net income (loss) $ (14,489)       (14,489)
Ending balance (in shares) at Sep. 30, 2023 188,313,807 188,313,807      
Ending balance at Sep. 30, 2023 $ (39,422) $ 2 $ 1,570,134 $ 6 $ (1,609,564)